Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05584449 · ClinicalTrials.gov registry record · NA

Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

A NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05584449 is a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05584449, a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Many AYA survivors typically do not feel prepared to re-enter "daily life" and would likely benefit from structured interventions to offer education and support in a timely manner as to prepare them for the challenges of life in survivorship. A 6-week group curriculum, designed to specifically meet the needs of AYA cancer survivors and facilitated by licensed social workers, may meet the unique needs of young adults who have survived a cancer diagnosis, and if so, the curriculum could be licensed and used across Mayo Clinic sites and potentially at other cancer centers nationwide.

Conditions Studied

Malignant Solid Neoplasm Hematopoietic and Lymphoid System Neoplasm

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Medical Chart Review
  • OTHER Counseling
  • PROCEDURE Discussion
  • OTHER Informational Intervention

Study Locations (1)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-01-16
Est. Completion 2027-10-18
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05584449

The ClinicalTrials.gov registry entry for NCT05584449 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT05584449 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05584449 about?

NCT05584449 is a clinical study titled "Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors". This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Many AYA survivors typically do not feel prepared to re-enter "daily life" and would likely benefit from structured interventions to offer educ...

What is the current status of trial NCT05584449?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-01-16. Estimated completion is 2027-10-18.

What conditions does trial NCT05584449 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm.

What interventions are being tested in trial NCT05584449?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Medical Chart Review (OTHER), Counseling (OTHER), Discussion (PROCEDURE), Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT05584449?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05584449 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Solid Neoplasm

All registered trials for this condition

Hematopoietic and Lymphoid System Neoplasm

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.